GHRP-6 vs Tesamorelin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
GHRP-6 is the original growth hormone releasing peptide, discovered by Cyril Bowers in the 1970s through systematic study of enkephalin analogs. It was the first molecule to reveal the existence of the ghrelin receptor pathway, predating the discovery of ghrelin itself....
Calculate GHRP-6 dose →Tesamorelin is an FDA-approved synthetic GHRH analog (Egrifta) modified with trans-3-hexenoic acid to resist DPP-IV enzymatic cleavage, doubling its effective half-life. It restores pulsatile GH secretion and preferentially reduces visceral adipose tissue. Approved in 2010 for HI...
Calculate Tesamorelin dose →| Parameter | GHRP-6 | Tesamorelin |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| Research | Extensively Studied | FDA Approved |
| Half-Life | ~15–60 min | ~26–38 min |
| Typical Dose | 100–300 µg | 1–2 mg |
| Frequency | 2–3× daily | Once daily |
| Route | Subcutaneous | Subcutaneous |
| FDA Status | Not Approved | Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.